SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Starfighters Space Inc

Starfighters Space Inc. ($FJET) is experiencing extreme volatility and trending due to its recent NYSE American listing and a massive post-IPO price surge. The community is highly divided, with many bullish traders anticipating a short squeeze fueled by its low float and high cost to borrow, while others are cautioning against a "pump and dump" given concerns about its early-stage operations and lack of revenue. This high-risk play is drawing significant attention within the broader "space stock" sector.

Ascent Solar Technologies, Inc. engages in the design, development, and manufacture of solar technology and power solutions for remote locations and extreme environments. It integrates photovoltaic modules into a variety of applications such as aerospace, defense, transportation, and electronic products. The company was founded by Mohan S. Misra and Joseph H. Armstrong on October 18, 2005 and is headquartered in Thornton, CO.

Ascent Solar Technologies Inc

Ascent Solar Technologies is drawing significant community attention following recent sharp price movements and trading halts, fueled by its flexible thin-film solar technology. Investors are actively debating the company's numerous teaming agreements and collaborations with defense and space organizations for applications ranging from lunar missions to drone powering, balancing excitement against historical concerns about dilution and operational funding.

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsværd, Denmark.

Novo Nordisk - ADR

Novo Nordisk A/S

Novo Nordisk is trending as the FDA approved its oral Wegovy pill, a significant milestone as the first GLP-1 oral therapy for weight management. The market is buzzing with excitement, hailing it as a game-changer that offers a convenient alternative to injections and potentially challenging competitors like Eli Lilly. Many investors anticipate a substantial rally and potential short covering following this development.

Aimei Health Technology Co., Ltd. is a blank check company, which engages in entering a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or similar business combination with one or more businesses. The company was founded on April 27, 2023 and is headquartered in New York, NY.

Aimei Health Technology Co Ltd

Aimei Health Technology (AFJK) is trending with intense volatility, primarily fueled by its extremely low public float following recent redemptions and an extended SPAC merger deadline. The community is actively discussing its potential for a significant short squeeze, drawing comparisons to other recent parabolic runners, while simultaneously expressing concerns over its fundamentals and the risks associated with such rapid price movements.

MannKind Corp. is a biopharmaceutical company, which focuses on the development and commercialization of innovative therapeutic products and devices to address serious unmet medical needs for those living with endocrine and orphan lung diseases. Its products and pipeline include Afrezza, Pediatric Afrezza, V-Go, Tyvaso DPI, MNKD-101, MNKD-201, MNKD-301, and MNKD-501. The company was founded by Alfred E. Mann on February 14, 1991 and is headquartered in Danbury, CT.

Mannkind Corp

Mannkind is trending due to recent positive regulatory news for FUROSCIX, including expanded pediatric approval and the acceptance of a new autoinjector application, alongside the anticipated launch of Afrezza in India. The community is actively debating the potential revenue impact of these developments and the company's partnership with United Therapeutics, while some shareholders express frustration over leadership actions and the stock's performance relative to broader biotech sector gains.

AppLovin Corp. engages in the development and operation of a mobile marketing platform. It offers AppDiscovery, MAX, Adjust, and SparkLabs. Its software-based platform caters to mobile application developers to improve the marketing and monetization of applications. The company was founded by Andrew Karam, John Krystynak, and Adam Foroughi in 2011 and is headquartered in Palo Alto, CA.

Applovin Corp - Ordinary Shares - Class A

Applovin Corp

Applovin is trending due to a wave of recent analyst price target upgrades, coupled with bullish sentiment surrounding its AI-driven ad platform and e-commerce expansion initiatives. However, community discussions are sharply divided, with many expressing concerns over its high valuation, reported insider selling, and notable put option activity, alongside resurfacing questions about an old SEC inquiry.

Sable Offshore Corp. engages in offshore oil and gas field operations. It focuses on developing the prolific Santa Ynez Unit in federal waters offshore California. The company was founded by James C. Flores on October 16, 2020 and is headquartered in Houston, TX.

Sable Offshore Corp.

Sable Offshore (SOC) is trending after federal regulators approved the restart plan for its Las Flores Pipeline System, reclassifying it as an interstate facility under federal oversight. This pivotal decision has the community deeply divided: bulls anticipate a significant catalyst for the controversial California offshore oil project and potential short squeeze, while bears remain wary of financial challenges and persistent state-level opposition.

Citigroup, Inc. is a holding company, which engages in the provision of financial products and services. It operates through the following segments: Services, Markets, Banking, Wealth, U.S. Personal Banking (USPB), and All Other. The Services segment includes Treasury and Trade Solutions (TTS) which provides an integrated suite of tailored cash management, trade, and working capital solutions to multinational corporations, financial institutions and public sector organizations, and Securities Services, which offers cross-border support for clients, providing on-the-ground local market expertise, post-trade technologies, customized data solutions, and a wide range of securities services solutions that can be tailored to meet client needs. The Markets segment provides corporate, institutional, and public sector clients around the world with a full range of sales and trading services across equities, foreign exchange, rates, spread products, and commodities. The Banking segment offers Investment Banking and Corporate Lending services. The Wealth segment includes Private Bank, Wealth at Work, and Citigold and provides financial services to a range of client segments through banking, lending, mortgages, investment, custody, and trust product offerings. The USPB segment includes Branded Cards and Retail Services, which have proprietary card portfolios and co-branded card portfolios within Branded Cards, and co-brand and private label relationships within Retail Services. The All Other segment consists of activities not assigned to the reportable operating segments, including certain unallocated costs of global functions, other corporate expenses, and net treasury results. The company was founded in 1812 and is headquartered in New York, NY.

Citigroup Inc

Citigroup is trending amid significant regulatory relief, with the community actively discussing how eased oversight and strategic moves like the Banamex stake sale could accelerate its transformation. This positive sentiment, reinforced by strong earnings and numerous analyst upgrades, is driving widespread bullishness, though a notable portion of investors remains cautious, highlighting extremely overbought technical indicators and anticipating a potential pullback.

Applied Optoelectronics, Inc. engages in the design and manufacture of optical communications products. Its products include optical devices, such as laser diodes, photodiodes, related modules and circuitry, and equipment for applications in fiber-to-the-home, cable television, point to point communications, and wireless. The company was founded by Chih Hsiang Lin on February 28, 1997 and is headquartered in Sugar Land, TX.

Applied Optoelectronics Inc

Applied Optoelectronics is trending due to surging demand for its 800G AI data center and 400G optical transceivers, supported by recent analyst upgrades and significantly raised price targets. The community is buzzing with bullish sentiment, discussing the potential for a short squeeze and a substantial re-rating as the optical sector benefits from the ongoing AI infrastructure build-out. Despite historical volatility, many anticipate continued upward momentum as production scales to meet hyperscaler needs.

Rocket Lab Corp. engages in the development of rocket launch and control systems for the space and defense industries. It operates through the Launch Services and Space Systems segments. The Launch Services segment provides launch services to customers on a dedicated mission or ride share basis. The Space Systems segment consists of spacecraft engineering and design services, spacecraft components, spacecraft manufacturing, and on-orbit mission operations. The company is headquartered in Long Beach, CA.

Rocket Lab Corp.

Rocket Lab USA Inc

Rocket Lab (RKLB) is trending after securing a significant contract from the U.S. Space Development Agency, substantially boosting its defense backlog and leading analysts to raise price targets. This development has ignited strong bullish sentiment, with the community actively debating the sustainability of its rapid ascent amidst broader enthusiasm for the space sector.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

INOVIO Reports Inducement Grant Under Inducement Plan

INOVIO Reports Inducement Grant Under Inducement Plan INOVIO Reports Inducement Grant Under Inducement Plan PR Newswire PLYMOUTH MEETING, Pa., Dec. 19, 2025 PLYMOUTH MEETING, Pa., Dec. 19, 2025...

INOVIO to Participate in December Investor Conferences

INOVIO to Participate in December Investor Conferences INOVIO to Participate in December Investor Conferences PR Newswire PLYMOUTH MEETING, Pa., Nov. 18, 2025 PLYMOUTH MEETING, Pa., Nov. 18, 2025...

Inovio (INO) Upgraded to Buy: Here's Why

Inovio (INO) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Inovio Pharmaceuticals (NASDAQ:INO) Announces Quarterly Earnings Results, Beats Expectations By $0.07 EPS

Inovio Pharmaceuticals (NASDAQ:INO - Get Free Report) posted its earnings results on Monday. The biopharmaceutical company reported ($0.44) EPS for the quarter, topping the consensus estimate of...

INOVIO Reports Third Quarter 2025 Financial Results and Recent Business Highlights

INOVIO Reports Third Quarter 2025 Financial Results and Recent Business Highlights INOVIO Reports Third Quarter 2025 Financial Results and Recent Business Highlights PR Newswire PLYMOUTH MEETING...

INOVIO to Report Third Quarter 2025 Financial Results on November 10, 2025

INOVIO to Report Third Quarter 2025 Financial Results on November 10, 2025 INOVIO to Report Third Quarter 2025 Financial Results on November 10, 2025 PR Newswire PLYMOUTH MEETING, Pa., Oct. 27, 2025...

INOVIO to Participate in the Stephens Biotechnology Virtual Fireside Chat Conference

INOVIO to Participate in the Stephens Biotechnology Virtual Fireside Chat Conference INOVIO to Participate in the Stephens Biotechnology Virtual Fireside Chat Conference PR Newswire PLYMOUTH MEETING...

Clinical Proof-of-Concept Data for DNA-Encoded Monoclonal Antibodies (DMAbs) Published in Nature Medicine

Clinical Proof-of-Concept Data for DNA-Encoded Monoclonal Antibodies (DMAbs) Published in Nature Medicine Clinical Proof-of-Concept Data for DNA-Encoded Monoclonal Antibodies (DMAbs) Published in...

INO Stock Soars as FDA Backs Rolling BLA for Rare Lung Disease Drug

Inovio stock surges 21% after the FDA gives green light to begin a rolling BLA for its RRP drug INO-3107, with plans to seek priority review.

PGEN Stock Surges 144% in August on FDA Nod for Rare Lung Disease Drug

Precigen stock soars 144% in August after FDA approval of Papzimeos, the first treatment for adults with recurrent respiratory papillomatosis.

Inovio Pharmaceuticals, Inc. engages in the provision of designed DNA medicines to treat and protect people from infectious diseases, cancer, and diseases associated with human papillomavirus. Its product pipeline includes VGX-3100, INO-3107, INO-5410, INO-4800, and PENNVAX-GP. The company was founded by David B. Weiner on June 29, 1983 and is headquartered in Plymouth Meeting, PA.

INO
Inovio Pharmaceuticals Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest INO News

INOInovio Pharmaceuticals Inc